HF
SHPH icon

HRT Financial’s Shuttle Pharmaceuticals SHPH Stock Holding History

HRT Financial’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-103
Closed -$34K – 3139
2024
Q3 		$34K Buy
+103
New +$63.2K ﹤0.01% 2145

Other funds holding SHPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's SHPH Position: Q4 2024 in Review

HRT Financial sold out of Shuttle Pharmaceuticals (SHPH) in Q4 2024, closing a stake of 103 shares — an estimated $34K sold.

HRT Financial first reported a position in SHPH in Q3 2024 and held it in 1 quarter. The position peaked at $34K in Q3 2024. 4 funds tracked by Wall St. Rank hold SHPH as of Q4 2024.

  • HRT Financial reported no remaining Shuttle Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 103 Shuttle Pharmaceuticals shares in Q4 2024, an estimated $34K.
  • HRT Financial first reported a position in Shuttle Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • HRT Financial's Shuttle Pharmaceuticals position peaked at $34K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.